Avoro Capital Advisors’s Medicines Co MDCO Stock Holding History

Avoro Capital Advisors’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-371,623	Closed	-$18.6M	–	40
2019 Q3	$18.6M	Sell	371,623 -553,377	-60%	-$22.1M	0.78%	25
2019 Q2	$33.7M	Sell	925,000 -637,000	-41%	-$20.8M	1.17%	21
2019 Q1	$43.7M	Buy	+1,562,000	New	+$36.8M	1.89%	16
2018 Q3	–	Sell	-961,574	Closed	-$35.3M	–	52
2018 Q2	$35.3M	Sell	961,574 -674,243	-41%	-$21.9M	1.36%	23
2018 Q1	$53.9M	Buy	1,635,817 +339,257	+26%	+$10.6M	2.57%	14
2017 Q4	$35.4M	Sell	1,296,560 -423,833	-25%	-$13.1M	2.3%	17
2017 Q3	$63.7M	Buy	1,720,393 +611,293	+55%	+$22.5M	4.94%	6
2017 Q2	$42.2M	Sell	1,109,100 -75,900	-6%	-$3.38M	5.32%	6
2017 Q1	$57.9M	Buy	+1,185,000	New	+$54M	7.4%	3

Other funds holding MDCO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Avoro Capital Advisors's MDCO Position: Q4 2019 in Review

Avoro Capital Advisors sold out of Medicines Co (MDCO) in Q4 2019, closing a stake of 371,623 shares — an estimated $18.6M sold.

Avoro Capital Advisors first reported a position in MDCO in Q1 2017 and held it in 9 quarters. The position peaked at $63.7M in Q3 2017. 284 funds tracked by Wall St. Rank hold MDCO as of Q4 2019.

Avoro Capital Advisors reported no remaining Medicines Co position as of Q4 2019 after selling out during the quarter.
Avoro Capital Advisors sold 371,623 Medicines Co shares in Q4 2019, an estimated $18.6M.
Avoro Capital Advisors first reported a position in Medicines Co in Q1 2017 and held it in 9 quarters.
Avoro Capital Advisors's Medicines Co position peaked at $63.7M in Q3 2017.
284 funds tracked by Wall St. Rank held Medicines Co as of Q4 2019.

Based on Avoro Capital Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.